| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.35 | 0.05 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |